Adalimumab

Diagnostic Use

Adalimumab (also known commercial names Amgevita or Humira),

Anti-drug antibodies are measured when drug levels are low (<2mg/L)

Delphic Registration Code

ADAL

Laboratory Handling

Phlebotomy

Serum samples should be taken from patients receiving TNF Biologics for at least 10 weeks. Samples should be taken at drug trough, within the 24 hours prior to a dose.

Registration

Register as ADAL; if uncertain register as TNF and Immunology will identify which specific drug to test.

Synonyms

Amgevita
Humira
Adalimumab antibodies

Turnaround Time

3 weeks

Specimen Type

• Serum

Specimen Requirements

Tube/Container Type:

Preferred

• Serum (Red Cap)

Preferred if West Coast

• SST II (Gold Cap)

Acceptable

• SST II (Gold Cap)

Preferred Sample Volume (ml)

1

Paediatric Specimen Requirements

Tube/Container Type:

Preferred

• Serum (Red Cap)

Acceptable

• SST II (Gold Cap)

Preferred Sample Volume (ml)

0.5

Pre-testing Requirements

Serum samples should be taken from patients receiving TNF Biologics for at least 10 weeks.
Samples should be taken at drug trough, within the 24 hours prior to a dose.
Please indicate on the request form the last dose date.

Aliquot Instructions

Sample Type

• Serum

Transport to Lab

Ambient (8 - 24 degrees Celsius)

Additional Referral/Aliquot Information

Samples may be transported to the lab chilled or ambient (2-24 degrees Celsius)
200uL serum (minimum), 1 mL serum (preferred)

Interpretation

Units mg/L

Reference Intervals

Test Method

Drug levels are measured by HLPC

Anti-drug antibodies are detected by HPLC.

Non-Funded Test Cost

$92.02 (Exclusive of GST)

Billing Code

5852

Additional Costing Information

An additional charge will apply for anti-drug antibody testing.

Contact Information

Enquiry Form